期刊文献+

酒石酸美托洛尔双脉冲片的研制 被引量:3

Preparation of Metoprolol Tartaric Acid Double-pulsatile Tablets
原文传递
导出
摘要 目的:制备酒石酸美托洛尔双脉冲片。方法:采用混合粉末直接压片法制备3层片芯(2层速释层和1层阻滞层),采用干压包衣技术制备杯形片,以时滞时间和累积释药率为指标,评价杯形片的顶层阻滞层辅料、用量以及压片硬度对释放行为的影响,确定片芯速释层和阻滞层处方及用量。结果:顶层阻滞层的辅料、用量以及压片硬度对释药时滞和累积释药率都有影响。确定了片芯速释层和阻滞层的处方和硬度;顶层阻滞层的用量为0.12g,可达到4h的第1个脉冲效果;片芯阻滞层的用量为70mg,可达到8h的第2个脉冲效果。结论:研制的酒石酸美托洛尔双脉冲片体外释放达到双脉冲要求。 OBJECTIVE:To prepare Metoprolol tartaric acid double-pulsatile tablets.METHODS:Mixed powder direct compression method was used to prepare 3 layers of tablet core(2 quick release layers and 1 blocking layer),and core-in-cup tablets were prepared by dry-compression coated technology.Effects of excipients and amount of top blocking layer of core-in-cup tablets and the hardness on drug release were evaluated using lag time and accumulative drug release rate as index to determine formula and amount of quick release layer and blocking layer.RESULTS:The excipients and amount of top blocking layer and the hardness had effect on lag time and accumulative drug release rate.The formula and hardness of quick release layer and blocking layer quantity were all determined;the amount of top blocking layer was 0.12 g,and the first pulse can be obtained at 4 h;the amount of blocking layer of core was 70 mg,and the second pulse can be obtained at 8 h.CONCLUSION:Metoprolol tartaric acid double-pulsatile tablets can meet the standard of double-pulsatile release.
出处 《中国药房》 CAS CSCD 2012年第9期825-828,共4页 China Pharmacy
关键词 酒石酸美托洛尔 双脉冲片 研制 片芯 阻滞层 累积释药率 Metoprolol tartaric acid Double-pulsatile tablets Preparation Tablet core Blocking layer Accumulative release rate
  • 相关文献

参考文献5

  • 1马安翠,杨建琴.时辰药理学与临床用药[J].大理学院学报(综合版),2008,7(6):3-5. 被引量:3
  • 2张玫.不同服药时间对心绞痛患者预后的影响[J].华北煤炭医学院学报,2009,11(4):511-512. 被引量:6
  • 3Jivraj II, Martini LG, Thomson CM. An overview of the different excipients useful for the direct compression of tablets[J]. Pharm Sci Technolo Today, 2000,3 (2) : 58.
  • 4郑俊民.药用辅料手册[M].北京:化学工业出版社,2005
  • 5Efentakis M, Koligliati S, Vlachou M. Design and evalua- tion of a dry coated drug delivery system with an imper- meable cup, swellable top layer and pulsatile release[J]. 1ntJPham,2006,311(2) :147.

二级参考文献16

共引文献26

同被引文献70

  • 1张莉,陈大为,高子彬.法莫替丁定时释放小丸的释药机制[J].药学学报,2006,41(9):873-877. 被引量:3
  • 2何绍雄 宋开源 薛振南.时间药理学与时间治疗学[M].天津:天津科学技术出版社,1998.227-251.
  • 3Kshirsagar SJ, S. V. Patil and M. R. Bhalekar, Statistical optimization of floating pulsatile drug delivery system for chronotherapy of hypertension [ J ]. Int J Pharm lnvestig, 2011 ;1(4) :207-213.
  • 4Elliott WJ, Ram cvs. Calcium channel blockers [ J ]. The Journal of Clinical Hpertension ,2011 ;9 ( 13 ) :687-689.
  • 5Schmltz P, Kleinebudde P. A new multi- particulate de- layedrelease system. Part 1 :dissolution properties and releasemechanism [ J ]. J Controlled Release, 1997 ; 47 (2) :181.
  • 6Narisaw S, Nagata M, Hirakawa Y. An organic acid- induced sigmoidal release system for oral controlled- release preparation m elucidation of the anomalous drug release behavio through osmotic pumping mechanism[ J. Int J Pharm, 1997 ;148( 1 ) :852-855.
  • 7Loh JP, Pendyala LK, Kitabata H, et al. Comparison of outcomes after percutaneous Coronary intervention among different coronary subsets(stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial Infarction)[J]. Am J Cardiol,2014, 113(11):1794-1801.
  • 8陈灏珠.实用内科学[M].北京:人民卫生出版社,2002:1373.
  • 9Das MK,Zipes DP. Anti-arrhythmic and non-anti-arrhythmic drugs for sudden cardiac death prevention [J]. J Cardio-vasic Phannacol, 2010,55 (5):438-449.
  • 10Ravens U. Novel pharmaeologieal approaehes for anti-arrhythmic therapy[J]. Naunyn Schmiede-bergs Arch Pharmaeol, 2010,381 (3):187-193.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部